Otonomy to Present at the Cantor Global Healthcare Conference
September 26 2019 - 4:05PM
Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company
dedicated to the development of innovative therapeutics for
neurotology, today announced that David A. Weber, Ph.D., president
and chief executive officer, will present at the 2019 Cantor Global
Healthcare Conference on Friday, October 4, 2019 at 12:35 p.m. ET
(9:35 a.m. PT) at the InterContinental New York Barclay Hotel in
New York City.
A live audio webcast and replay of the presentation will be
available through the Events and Presentations page of the
company's website (www.otonomy.com).
About Otonomy
Otonomy is a biopharmaceutical company dedicated to the
development of innovative therapeutics for neurotology. The company
pioneered the application of drug delivery technology to the ear in
order to develop products that achieve sustained drug exposure from
a single local administration. This approach is covered by a broad
patent estate and is being utilized to develop a pipeline of
products addressing important unmet medical needs including
Ménière’s disease, hearing loss, and tinnitus. For additional
information please visit www.otonomy.com.
Contacts:
Media Inquiries Spectrum Leticia Diaz Vice President
202.587.2517ldiaz@spectrumscience.com
Investor InquiriesWestwicke PartnersRobert H. UhlManaging
Director858.356.5932robert.uhl@westwicke.com
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Otonomy (NASDAQ:OTIC)
Historical Stock Chart
From Jul 2023 to Jul 2024